Navigation Links
Neurocrine Biosciences Reports Third Quarter 2011 Results
Date:10/31/2011

>

The Company has completed several Phase I studies and two Phase II studies of urocortin 2 in patients with stable congestive heart failure. These Phase II studies showed urocortin 2 to be well tolerated with positive hemodynamic effects as evidenced by increases in cardiac output and efficiency.

Conference Call and Webcast Today at 5:00PM Eastern TimeNeurocrine will hold a live conference call and webcast today at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Participants can access the live conference call by dialing 800-862-9098 (US) or 785-424-1051 (International) using the conference ID: NBIX. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the conference call will be available approximately one hour after the conclusion of the call by dialing 800-695-0974 (US) or 402-220-1459 (International) using the conference ID: NBIX. The call will be archived for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

In addition to historical facts, this press release may contain forward-looking statements that involve a number of risks and uncertainties. Among the factors that could cause actual results to differ m
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
2. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2008 Financial Results
4. Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference
5. Webcast Alert: Neurocrine Announces 3Q 08 Financial Results
6. Neurocrine Biosciences Reports Third Quarter 2008 Results
7. Neurocrine Biosciences to Present at the 20th Annual Piper Jaffray Health Care Conference
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results
9. Neurocrine Biosciences to Present at the Cowen and Company 29th Annual Health Care Conference
10. Neurocrine Biosciences to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
11. Neurocrine Announces Work Force Restructuring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 2014  ImmunoClin Corporation (IMCL) is a U.S. ... infectious diseases as well as nutraceuticals. The company ... pathologies like cardiovascular disease, Alzheimer,s disease and gastrointestinal ... will complete the strategic relocation of its corporate ... a key center of North American healthcare and ...
(Date:7/29/2014)... ST. LOUIS , July 29, 2014  Sigma-Aldrich ... global water and energy use, increased its investment in ... community service around the world last year, the Company ... Report: What if Science Changed the World? ... has earned several honors for being a responsible corporate ...
(Date:7/29/2014)... The first product launch from start-up Hurley ... robotics. What sets Droidles completely apart from other stand ... them to communicate, share code with each other and ... “The invention is the system,” said Hurley Research founder ... of their own, both physically and on the internet." ...
(Date:7/29/2014)... FL (PRWEB) July 29, 2014 EXpressLO ... situ lift out specimen preparation solutions, has been granted ... Office for specimen manipulation methods incorporating a unique specimen ... This is the second company patent for EXpressLO ... Giannuzzi. , These complementary patents extend EXpressLO’s ...
Breaking Biology Technology:ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 2ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 3Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 2Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 3Droidles, the Social Network of Robots and Open Source Platform for the Internet of Things, Launches for Crowd Funding on IndieGoGo.com 2EXpressLO LLC Granted Second U.S. Patent for Innovative Specimen Preparation Methods 2
... CBM ) reports third quarter results for the period ... Reported sales decreased by 14.6%, and excluding the impact ...   Adjusted EBITDA was $8.5 million in the third quarter ... Debt, net of cash was $71.4 million at the end ...
... Life Sciences Holdings, Inc. (OTC Bulletin Board: ... discovery, development and commercialization of novel drugs in the therapeutic ... the Company has been awarded a cash grant under the ... part of the Patient Protection and Affordable Care Act of ...
... (OTC Bulletin Board: CVAT, Berlin & Stuttgart: WTC) proudly announces ... Frankfurt Stock Exchange under the ticket symbol WTC. ... another milestone with the listing on the Frankfurt Stock Exchange ... us gain visibility and support in the European market.  The ...
Cached Biology Technology:Cambrex Reports Third Quarter 2010 Results 2Cambrex Reports Third Quarter 2010 Results 3Cambrex Reports Third Quarter 2010 Results 4Cambrex Reports Third Quarter 2010 Results 5Cambrex Reports Third Quarter 2010 Results 6Cambrex Reports Third Quarter 2010 Results 7Cambrex Reports Third Quarter 2010 Results 8Cambrex Reports Third Quarter 2010 Results 9IRS Awards Cash Grant to Advanced Life Sciences Under the Qualifying Therapeutic Discovery Project 2IRS Awards Cash Grant to Advanced Life Sciences Under the Qualifying Therapeutic Discovery Project 3Listing on Frankfurt Stock Exchange for CTI (http://ctinanotech.com) 2Listing on Frankfurt Stock Exchange for CTI (http://ctinanotech.com) 3
(Date:7/29/2014)... University of Kent has shown for the first time ... breakthrough that could have a major impact on cancer ... Biosciences uncovered the mechanism whereby the physical properties of ... filaments are ,fine-tuned, to undertake different functions. , ... stable, providing a framework for the cell, others are ...
(Date:7/29/2014)... JULY 2014 With thirty days to go and ... FEBS-EMBO 2014 Conference are well underway. The event, a ... (FEBS), EMBO, and the French Society for Biochemistry and ... August to Thursday, 4 September at the Palais des ... is the largest meeting for the life sciences in ...
(Date:7/29/2014)... two of the major disciplines behind Jurassic Park is ... stunning photographs and unique illustrations. , Fossil Insects, by ... incredible preservation and diversity of fossilised insects from around ... fossils can tell us about the ancient and modern ... the mosquito in Jurassic Park, many of the hundreds ...
Breaking Biology News(10 mins):Counting down to FEBS-EMBO 2014 in Paris, France 2Unique images bring fossil insects back to life 2
... Ont., July 12, 2001--Eating nuts every day could help ... to new research from St. Michael,s Hospital and the ... by the journal Diabetes Care , a team ... Toronto Department of Nutritional Sciences; St. Michael,s Hospital Risk ...
... Beach, FL. Research to be presented at the ... of Ingestive Behavior (SSIB), the foremost society for research ... that caffeine added to sugar-sweetened, carbonated beverages teaches adolescents ... amount of caffeine added to an unfamiliar beverage was ...
... Research to be presented at the upcoming annual meeting of ... foremost society for research into all aspects of eating and ... increases our willingness to pay for food, while simultaneously decreasing ... ever wondered about why you are willing to pay more ...
Cached Biology News:A 'nutty' solution to type 2 diabetes management 2
...
... and Tissue Staining Kits are intended for ... of histological and cytological specimens. These kits ... manufactured by either R&D Systems or by ... the formation of the Avidin-Biotin Complex (ABC) ...
... jetSI-ENDO is an easy-to-use siRNA transfection ... out endogenous genes in a variety of ... comes with an optimized, straightforward protocol. High ... are obtained following transfection of 20 to ...
... is a tetramethylrhodamine-conjugated jetSI-ENDO (excitation ... 580 nm), the powerful siRNA ... used to determine the transfection ... delivery and trafficking of siRNAs. ...
Biology Products: